Research Antibodies and Reagents Market Worth $6.32 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research

LONDON, Nov. 18, 2020 /PRNewswire/ -- According to a new market research report "Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027", published by Meticulous Research, the research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to reach $6.32 billion by 2027.


Download Free Sample Report Now @

Impact of COVID-19 on the Research Antibodies and Reagents Market

The COVID-19 pandemic has had a huge impact on the overall healthcare industry. There is currently no specific treatment for COVID-19. Researchers worldwide are investigating preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines, and antivirals, and investigating the repurposing of existing drugs to treat the infection.

  • In September 2020, research at Regeneron Pharmaceuticals concluded that a combination of two monoclonal antibodies could work as treatments in coronavirus infected people.
  • In April 2020, AstraZeneca (U.K.) joined forces United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the University of Maryland School of Medicine to discover novel coronavirus-neutralizing antibodies.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:

Key Findings in the Research Antibodies and Reagents Market Study

The research antibodies and reagents market study present historical market data in terms of value (2018 and 2019), estimated current data (2020), and forecasts for 2027 by product, technology, application, and end user. The study also evaluates industry competitors at the regional and country levels.

Based on product, the research antibodies segment is expected to command the largest share of the overall research antibodies and reagents market in 2020 due to growing protein or cell-based research, increasing funding for the R&D sector, rising need for disease-specific biomarkers, and widespread application in biomarker discovery.

In 2020, based on end-user, the pharmaceutical & biotechnology industry segment is poised to command the largest share of the overall research antibodies and reagents market due to rising research activities with a growing number of diseases, the need for biomarker discovery for better diagnosis & therapy, and increasing drug development programs.

In 2020, geographically, North America is projected to dominate the global research antibodies and reagents market, followed by Europe and Asia-Pacific. Factors such as a well-established healthcare system, acceptance of advanced technologies, rising non-communicable diseases, increasing drug discovery programs & related rise in pharmaceutical research & development, rising focus on proteomics and genomics research, higher research funding, and presence of key players are driving the growth of this market.

Quick Buy – Research Antibodies and Reagents Market Research Report: 

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past few years. The key players operating in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA , Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG , Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza , Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited , Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here:

Scope of the Report:

Research Antibodies and Reagents Market, by Product

  • Antibodies
    • Antibodies Market, by Type
      • Primary Antibody
      • Secondary Antibody
    • Antibodies Market, by Production Type
      • Monoclonal Antibody
      • Polyclonal Antibody
      • Antibody Fragments
    • Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Others
    • Antibodies Market, by Research Area
      • Oncology
      • Infectious Diseases
      • Cardiovascular Disease
      • Immunology
      • Neurology
      • Stem Cell Research
      • Others
  • Reagents
    • Sample Preparation Reagents
      • Media and Serum
      • Stain and Dyes
      • Probes
      • Buffers
      • Solvents
    • Antibody Production Reagents
      • Enzymes
      • Proteins
    • Other Research Reagents

Research Antibodies and Reagents Market, by Technology

  • Flow Cytometry
  • Immunofluorescence
  • Enzyme-Linked Immunosorbent Assay
  • Multiplex Immunosorbent Assay
  • Western Blot
  • Immunohistochemistry
  • Immunoprecipitation (IP)
  • Others

Research Antibodies and Reagents Market, by Application

  • Proteomics
  • Drug Discovery and Development
  • Genomics

Research Antibodies and Reagents Market, by End User

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Research Antibodies and Reagents Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Download Free Sample Report Now @

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-

Related Reports:

Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area (Oncology, Immunology), End User (Pharma and Biotech, Medical Device), and Geography - Forecast to 2027

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027

Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Mr. Khushal Bombe
Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Visit Our Website:
Connect with us on LinkedIn-
Content Source:    


Cision View original content:

SOURCE Meticulous Market Research Pvt. Ltd

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.